Back to today’s briefing

Story perspectives

Doctors Cure Fetal SMA with Innovative Prenatal Treatment

2/25/2025

50 10

Summary

Story summary

In a groundbreaking achievement, doctors in the US and Switzerland treated a fetus for spinal muscular atrophy (SMA) type 1 with Risdiplam during pregnancy. Administered at 32 weeks, the treatment led to the birth of a healthy baby free from the disease. This remarkable success paves the way for innovative prenatal therapies, highlighting the power of early intervention in combating genetic disorders.

1 of 1

Story summary

In a groundbreaking achievement, doctors in the US and Switzerland treated a fetus for spinal muscular atrophy (SMA) type 1 with Risdiplam during pregnancy. Administered at 32 weeks, the treatment led to the birth of a healthy baby free from the disease. This remarkable success paves the way for innovative prenatal therapies, highlighting the power of early intervention in combating genetic disorders.